n-methylaspartate has been researched along with tranexamic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishibashi, N; Jonas, RA; Korotcova, L; Lu, Z; Murata, A | 1 |
Béjot, Y; Garnier, P; Jacquin, A; Marie, C; Mossiat, C; Prigent-Tessier, A; Rodier, M | 1 |
2 other study(ies) available for n-methylaspartate and tranexamic acid
Article | Year |
---|---|
Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model.
Topics: Aminocaproic Acid; Animals; Animals, Newborn; Antifibrinolytic Agents; Apoptosis; Aprotinin; Caspases; Cerebral Cortex; Coculture Techniques; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Excitatory Amino Acid Agonists; Feeder Cells; Gestational Age; Mice; N-Methylaspartate; Neuroglia; Neurons; Neuroprotective Agents; Signal Transduction; Time Factors; Tranexamic Acid | 2014 |
Exogenous t-PA administration increases hippocampal mature BDNF levels. plasmin- or NMDA-dependent mechanism?
Topics: Animals; Brain-Derived Neurotrophic Factor; Dizocilpine Maleate; Fibrinolysin; Hippocampus; Male; N-Methylaspartate; Protein Precursors; Rats, Wistar; Receptor, trkB; Tissue Plasminogen Activator; Tranexamic Acid | 2014 |